Skip to main content
LENZ logo
LENZ
(NASDAQ)
LENZ Therapeutics, Inc.
$5.05-- (--)
Loading... - Market loading

LENZ Therapeutics (LENZ) Stock Price & Financial Analysis

LENZ Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$5.01 - $5.42
52-Week High$50.40
52-Week Low$4.68
Open$5.26
Volume613.30K
Average Volume (3M)953.39K
Market Cap167.42M
Shares Outstanding31.35M
Price to Sales (P/S)7.29
Price to Book (P/B)0.62
EV/EBITDA-1.12
Revenue (TTM)20.99M
Net Income (TTM)-109.00M
Free Cash Flow (TTM)-87.44M
EPS (TTM)$-3.66
Profit Margin-519.30%
Operating Margin-563.83%
Return on Equity (ROE)-44.22%
Debt to Equity0.00
50-Day MA$6.75
200-Day MA$16.67
52-Week Change-85.88%
Annual Dividend$0.00
Dividend Yield0.00%
Last Dividend Ex-DateMar 22, 2024

Frequently Asked Questions About LENZ Therapeutics

What is the current stock price for LENZ?

As of the latest trading session, LENZ stock trades at $5.05. The 52-week range is $4.68–$50.40, with a day range of $5.01–$5.42.

What is the P/E ratio for LENZ?

The P/E ratio (Price-to-Earnings) for LENZ is shown in the Key Statistics section. This valuation metric helps compare LENZ Therapeutics, Inc. to industry peers.

Does LENZ pay dividends?

LENZ Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for LENZ?

Based on 6 analysts, the consensus for LENZ is Buy.

What is the market cap of LENZ?

LENZ Therapeutics's market capitalization is $158.3M, classifying it as a micro-cap company. LENZ Therapeutics operates in the Healthcare sector within the Biotechnology industry.